Erste Asset Management’s Viking Therapeutics VKTX Stock Holding History

Erste Asset Management’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.86M	Hold	47,000	–	–	0.01%	388
2026 Q1	$1.41M	Hold	47,000	–	–	0.01%	408
2025 Q4	$1.71M	Hold	47,000	–	–	0.01%	368
2025 Q3	$1.21M	Hold	47,000	–	–	0.01%	397
2025 Q2	$1.25M	Hold	47,000	–	–	0.01%	462
2025 Q1	$1.21M	Hold	47,000	–	–	0.02%	359
2024 Q4	$1.93M	Hold	47,000	–	–	0.02%	331
2024 Q3	$2.9M	Buy	47,000 +16,000	+52%	+$939K	0.03%	280
2024 Q2	$1.57M	Hold	31,000	–	–	0.02%	332
2024 Q1	$2.58M	Sell	31,000 -49,000	-61%	-$2.18M	0.04%	282
2023 Q4	$1.54M	Buy	+80,000	New	+$1.05M	0.02%	325

Other funds holding VKTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Erste Asset Management's VKTX Position: Q2 2026 in Review

Erste Asset Management held its Viking Therapeutics (VKTX) position steady in Q2 2026 at 47,000 shares worth $1.86M. The position accounts for 0.01% of the portfolio, ranked #388.

Erste Asset Management first reported a position in VKTX in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.9M in Q3 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

Erste Asset Management held 47,000 shares of Viking Therapeutics worth $1.86M as of Q2 2026.
Erste Asset Management left its Viking Therapeutics share count unchanged in Q2 2026.
Viking Therapeutics made up 0.01% of Erste Asset Management's portfolio in Q2 2026, its #388 holding.
Erste Asset Management first reported a position in Viking Therapeutics in Q4 2023 and has held it in 11 quarters since.
Erste Asset Management's Viking Therapeutics position peaked at $2.9M in Q3 2024.
432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.